{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:40:10Z","timestamp":1741984810543,"version":"3.38.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/mbc.0b013e32834cb372","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T09:40:33Z","timestamp":1322905233000},"page":"23-29","source":"Crossref","is-referenced-by-count":4,"title":["An algorithmic approach to peripheral artery disease in hemophilia"],"prefix":"10.1097","volume":"23","author":[{"given":"Patrick F.","family":"Fogarty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Olin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"Konkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis M.","family":"Aledort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-3-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2141.1989.tb06277.x","article-title":"Mortality and causes of death in Dutch haemophiliacs, 1973-86.","volume":"71","author":"Rosendaal","year":"1989","journal-title":"Br J Haematol"},{"key":"R4-3-20210203","doi-asserted-by":"crossref","first-page":"823","DOI":"10.7326\/0003-4819-123-11-199512010-00002","article-title":"Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986.","volume":"123","author":"Triemstra","year":"1995","journal-title":"Ann Intern Med"},{"key":"R5-3-20210203","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2006-10-050435","article-title":"Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.","volume":"110","author":"Darby","year":"2007","journal-title":"Blood"},{"key":"R7-3-20210203","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1538-7836.2009.03669.x","article-title":"Coronary atherosclerosis and cardiovascular mortality in hemophilia.","volume":"8","author":"Foley","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R9-3-20210203","doi-asserted-by":"crossref","first-page":"III27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis.","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"R10-3-20210203","doi-asserted-by":"crossref","first-page":"52M","DOI":"10.1016\/j.amjcard.2005.10.006","article-title":"Relation of endothelial cell function to erectile dysfunction: implications for treatment.","volume":"96","author":"Guay","year":"2005","journal-title":"Am J Cardiol"},{"key":"R11-3-20210203","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4065\/mcp.2010.0133","article-title":"Peripheral artery disease. Current insight into the disease, diagnosis and management.","volume":"85","author":"Olin","year":"2010","journal-title":"Mayo Clinic Proc"},{"key":"R12-3-20210203","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.","volume":"110","author":"Selvin","year":"2004","journal-title":"Circulation"},{"issue":"Suppl 4","key":"R13-3-20210203","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3949\/ccjm.73.Suppl_4.S8","article-title":"Pathophysiology of peripheral arterial disease and risk factors for its development.","volume":"73","author":"Bartholomew","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"R14-3-20210203","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACCAHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular SurgerySociety for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACCAHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"R15-3-20210203","doi-asserted-by":"crossref","first-page":"Abstract3901","DOI":"10.1161\/circ.114.suppl_18.II_W-a","article-title":"Young patients infected with HIV have increased prevalence of peripheral arterial disease.","volume":"114","author":"Jang","year":"2006","journal-title":"Circulation"},{"key":"R16-3-20210203","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/hc3501.094232","article-title":"Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency.","volume":"104","author":"Sramek","year":"2001","journal-title":"Circulation"},{"key":"R17-3-20210203","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care.","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"R18-3-20210203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2261-10-35","article-title":"Prevalence of peripheral arterial disease in patients at nonhigh cardiovascular risk. Rationale and design of the PANDORA study.","volume":"10","author":"Cimminiello","year":"2010","journal-title":"BMC Cardiovasc Disord"},{"key":"R19-3-20210203","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.0000128517.52533.DB","article-title":"Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association.","volume":"109","author":"Faxon","year":"2004","journal-title":"Circulation"},{"key":"R20-3-20210203","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease.","volume":"326","author":"Criqui","year":"1992","journal-title":"N Engl J Med"},{"issue":"Abstract","key":"R21-3-20210203","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood.V106.11.4060.4060","article-title":"A hemophilia patient with C1 domain Arg2150HIS mutation developed a high titer inhibitor not inhibiting autologous factor VIII after switching to third generation recombinant product.","volume":"106","author":"Gerhardt","year":"2005","journal-title":"Blood"},{"key":"R22-3-20210203","first-page":"9","article-title":"Antiplatelet therapy: a vascular medicine perspective.","volume":"9","author":"Olin","year":"2000","journal-title":"Manag Care"},{"issue":"Suppl S","key":"R23-3-20210203","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"R24-3-20210203","doi-asserted-by":"crossref","first-page":"Abstract1216","DOI":"10.1182\/blood.V112.11.1216.1216","article-title":"Atherosclerosis and predictors of cardiovascular mortality in hemophilia.","volume":"112","author":"Foley","year":"2008","journal-title":"Blood"},{"key":"R25-3-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1532-5415.1985.tb02853.x","article-title":"Update on some epidemiologic features of intermittent claudication: the Framingham Study.","volume":"33","author":"Kannel","year":"1985","journal-title":"J Am Geriatr Soc"},{"key":"R26-3-20210203","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/01.CIR.91.5.1472","article-title":"Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study.","volume":"91","author":"Hiatt","year":"1995","journal-title":"Circulation"},{"key":"R27-3-20210203","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","article-title":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"R28-3-20210203","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.97.5.437","article-title":"Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.","volume":"97","author":"Robinson","year":"1998","journal-title":"Circulation"},{"key":"R29-3-20210203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/ejvs.2001.1437","article-title":"Prevalence and significance of thrombophilia in peripheral arterial disease.","volume":"22","author":"Burns","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R30-3-20210203","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.amjcard.2009.06.068","article-title":"Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease.","volume":"104","author":"Baber","year":"2009","journal-title":"Am J Cardiol"},{"key":"R31-3-20210203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1758-2652-13-12","article-title":"Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study.","volume":"13","author":"Jang","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"R32-3-20210203","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1351-8216.2003.00821.x","article-title":"Renal disease among males with haemophilia.","volume":"9","author":"Kulkarni","year":"2003","journal-title":"Haemophilia"},{"key":"R33-3-20210203","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccl.2005.03.006","article-title":"Management of peripheral arterial disease in chronic kidney disease.","volume":"23","author":"OHare","year":"2005","journal-title":"Cardiol Clin"},{"key":"R34-3-20210203","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction.","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med"},{"key":"R35-3-20210203","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/CIRCULATIONAHA.106.683722","article-title":"Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies.","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"},{"key":"R36-3-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1358863X08089276","article-title":"A biomarker panel for peripheral arterial disease.","volume":"13","author":"Fung","year":"2008","journal-title":"Vasc Med"},{"key":"R37-3-20210203","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.CIR.88.3.837","article-title":"Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.","volume":"88","author":"Newman","year":"1993","journal-title":"Circulation"},{"key":"R38-3-20210203","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/archinte.158.12.1357","article-title":"Physical examination and chronic lower-extremity ischemia: a critical review.","volume":"158","author":"McGee","year":"1998","journal-title":"Arch Intern Med"},{"key":"R39-3-20210203","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).","volume":"31","author":"Dormandy","year":"2000","journal-title":"J Vasc Surg"},{"key":"R40-3-20210203","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.1993.03510040069031","article-title":"Decreased anklearm blood pressure index and mortality in elderly women.","volume":"270","author":"Vogt","year":"1993","journal-title":"JAMA"},{"key":"R41-3-20210203","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.CIR.0000112642.63927.54","article-title":"Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study.","volume":"109","author":"Resnick","year":"2004","journal-title":"Circulation"},{"key":"R42-3-20210203","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","article-title":"Medical treatment of peripheral arterial disease and claudication.","volume":"344","author":"Hiatt","year":"2001","journal-title":"N Engl J Med"},{"key":"R43-3-20210203","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1358863X9700200312","article-title":"Clinical assessment of the patient with claudication: the role of the vascular laboratory.","volume":"2","author":"Creager","year":"1997","journal-title":"Vasc Med"},{"key":"R44-3-20210203","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1161\/01.CIR.94.11.3026","article-title":"Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review.","volume":"94","author":"Weitz","year":"1996","journal-title":"Circulation"},{"key":"R45-3-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5694\/j.1326-5377.1983.tb99395.x","article-title":"The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease.","volume":"1","author":"Faulkner","year":"1983","journal-title":"Med J Aust"},{"key":"R46-3-20210203","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.1991.00400070161023","article-title":"The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group.","volume":"151","year":"1991","journal-title":"Arch Intern Med"},{"key":"R48-3-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3949\/ccjm.71.1.58","article-title":"How to use statins in patients with chronic liver disease.","volume":"71","author":"Russo","year":"2004","journal-title":"Cleveland Clinic J Med"},{"key":"R49-3-20210203","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2516.2009.02066.x","article-title":"Emerging clinical concerns in the ageing haemophilia patient.","volume":"15","author":"Konkle","year":"2009","journal-title":"Haemophilia"},{"key":"R50-3-20210203","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"R51-3-20210203","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/diacare.26.12.3333","article-title":"Peripheral arterial disease in people with diabetes.","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"R52-3-20210203","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2005.09.065","article-title":"Peripheral arterial disease in patients with diabetes.","volume":"47","author":"Marso","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R53-3-20210203","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jama.1995.03530120067043","article-title":"Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.","volume":"274","author":"Gardner","year":"1995","journal-title":"JAMA"},{"key":"R54-3-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R55-3-20210203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0140-6736(92)93216-A","article-title":"Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians Health Study.","volume":"340","author":"Goldhaber","year":"1992","journal-title":"Lancet"},{"key":"R56-3-20210203","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0037-1615621","article-title":"Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.","volume":"85","author":"White","year":"2001","journal-title":"Thromb Haemost"},{"key":"R57-3-20210203","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"R58-3-20210203","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"2nd, Martin JD, Bortey EB, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication.","volume":"109","author":"Dawson","year":"2000","journal-title":"Am J Med"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-201201000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:01:31Z","timestamp":1741982491000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201201000-00003"}},"subtitle":["extrapolation of management principles from noncoagulopathic patients"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32834cb372","relation":{},"ISSN":["0957-5235"],"issn-type":[{"type":"print","value":"0957-5235"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}